Quest Diagnostics Declares Quarterly Cash Dividend
Quest Diagnostics (NYSE: DGX) has announced that its Board of Directors has declared a quarterly cash dividend of $0.75 per share.
Rhea-AI Summary
Quest Diagnostics (NYSE: DGX) has announced that its Board of Directors has declared a quarterly cash dividend of $0.75 per share.
This dividend will be payable on July 22, 2024, to shareholders who hold Quest Diagnostics common stock as of July 8, 2024.
Quest Diagnostics is recognized as a leader in diagnostic information services.
Positive
- Declaration of $0.75 per share quarterly cash dividend.
- Dividend payable date set as July 22, 2024.
- Record date for shareholders established as July 8, 2024.
- Consistent dividend payment reinforces financial stability.
Negative
- No new information on revenue or business growth provided.
- No updates on potential risks or financial challenges.
Details
News Market Reaction – DGX
In the trading session that priced this news, DGX gained 1.17%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from the world's largest database of deidentified clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-declares-quarterly-cash-dividend-302146947.html
SOURCE Quest Diagnostics
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.